AlphaStocks
3.4
Weak

LifeStance Health Group, Inc. (LFST)

As of Sep 19, 2026, LifeStance Health Group, Inc. (LFST) scores 3.4/10 on AlphaStocks' five-model composite, #151 of 168 Health Care stocks.

Health Care / Health Care Services

S&P SmallCap 600

$12.57

Scores poorly across most models. Proceed with caution.

Weak

Score based on 4 of 5 models — moderate confidence

Data as of Sep 19, 2026

#151out of 168 in Health Care

Is LifeStance Health Group, Inc. a Good Investment in 2026?

LifeStance Health Group, Inc. (LFST) scores 3.4 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Piotroski model rates LifeStance Health Group, Inc. as Strong (7/9). However, the Greenblatt Magic Formula model rates it Caution — Earnings yield 0.6% · ROC 7%. LifeStance Health Group, Inc. ranks #151 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

ROE0.6Market Cap5B

Valuation

Trades at 509x earnings — significantly above sector median of 30x. Premium reflects market growth expectations.

Fair value estimate not available for this stock.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Strong

7/9

Buffett

Caution

Business quality & competitive moat

Graham

Caution

Significantly above fair value

Lynch

Limited Data

Growth rate vs price (PEG)

Greenblatt

Caution

Earnings yield 0.6% · ROC 7%

Frequently Asked Questions

Is LifeStance Health Group, Inc. (LFST) a good investment?
As of Sep 19, 2026, LifeStance Health Group, Inc. (LFST) scores 3.4/10 on AlphaStocks' five-model composite, #151 of 168 Health Care stocks. That score is below average, suggesting caution. Trades at 509x earnings — significantly above sector median of 30x. Premium reflects market growth expectations.
What is LifeStance Health Group, Inc.'s Piotroski F-Score?
LifeStance Health Group, Inc.'s Piotroski F-Score status is Strong. The raw score is 7/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is LFST overvalued or undervalued?
A precise fair value estimate is not available for LFST. Trades at 509x earnings — significantly above sector median of 30x. Premium reflects market growth expectations.
How does LFST compare to other Health Care stocks?
LifeStance Health Group, Inc. ranks #151 out of 168 stocks in the Health Care sector, placing it in the top 90% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about LFST?
AlphaStocks evaluates LFST using five proven investment models. Piotroski: Strong; Buffett: Caution; Graham: Caution; Greenblatt Magic Formula: Caution. These models are combined into a single composite score of 3.4/10.

Similar Stocks

Compare LFST with

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer